Researchers at Barcelona's Instituto de Investigación Sant Pau are challenging the idea that depression has one biological pattern. Their review links symptoms such as anhedonia, rumination, insomnia and suicidal behaviour to different patterns of brain connectivity.
Researchers at the Instituto de Investigación Sant Pau in Barcelona reviewed how specific depression symptoms relate to brain connectivity at rest. Their findings point to different patterns linked to anhedonia, rumination, insomnia and suicidal behaviour.
Depression may not be one brain disorder with one biological signature. The same formal diagnosis can cover very different clinical realities. Patients may meet the criteria for major depressive disorder but differ sharply in their symptoms and their intensity.
The label is broad.
В независимом сообщении о более широком исследовании большой депрессии описаны 263 пациента и 75 здоровых участников; анализ выявил пять профилей мозговой связности, связанных с различными клиническими чертами.
The study was published in Translational Psychiatry. Researchers examined existing evidence on functional connectivity at rest. They focused on clinical dimensions rather than treating depression as one uniform condition.
Earlier neurobiological reviews point in the same direction. Anhedonia has been linked to altered connectivity in reward-related systems. Rumination has been linked to activity or connectivity in the default mode network.
The current diagnostic system requires a minimum number of symptoms from internationally recognised manuals. Several combinations can lead to the same diagnosis. That flexibility helps clinicians identify depression, but it also creates wide differences among patients with the same label.
That is the problem.
When researchers group patients with different symptom profiles together, consistent brain biomarkers become harder to find. Predicting who will respond to a particular treatment also becomes more difficult.
Материал в <em>British Journal of Psychiatry</em> отмечает, что выраженная анедония связана с суицидальными мыслями и поведением даже после учета общей тяжести депрессии. Это усиливает интерес к симптомно-ориентированной стратификации риска, но не превращает такой показатель в самостоятельный диагностический тест.
The proposed alternative is dimensional. Doctors would begin with the symptom that defines a patient's clinical picture. They would then examine the brain circuits associated with it.
Anhedonia may involve a different connectivity pattern from rumination or insomnia. Suicidal behaviour may also show its own configuration. The review does not present a finished diagnostic test. It lays out evidence for a direction in future research and more precise clinical work.
This gap between a formal category and the conditions hidden inside it also appeared in an earlier report about how broad labels can obscure the details that shape what happens next.
A dimensional approach could help explain why two people with major depressive disorder follow different courses. They may also respond differently to the same treatment.
The target would no longer be only the diagnostic label. It would include the patient's symptom pattern and the brain circuitry linked to it. That could give personalised psychiatry a clearer path.
Reviews of rumination add context to this model. They connect repetitive self-focused thinking with the default mode network, a system involved in internally oriented thought.
The study's main contribution is straightforward. It does not treat diagnostic convenience as biological truth.
The evidence reviewed by IR Sant Pau supports a model in which depression includes partly distinct clinical dimensions rather than one homogeneous brain condition. Reports on Finnish brain-profile research describe the same wider effort to identify biologically meaningful subgroups.
The British Journal of Psychiatry has also highlighted the clinical relevance of anhedonia beyond overall depression severity. None of this replaces established diagnosis. It does support more specific assessment and treatment decisions tied to a patient's actual symptoms.
